Logo image of CYN

CYNGN INC (CYN) Stock Fundamental Analysis

USA - NASDAQ:CYN - US23257B3050 - Common Stock

6.22 USD
+0.39 (+6.69%)
Last: 10/2/2025, 8:00:01 PM
6.1 USD
-0.12 (-1.93%)
After Hours: 10/2/2025, 8:00:01 PM
Fundamental Rating

4

Taking everything into account, CYN scores 4 out of 10 in our fundamental rating. CYN was compared to 281 industry peers in the Software industry. No worries on liquidiy or solvency for CYN as it has an excellent financial health rating, but there are worries on the profitability. CYN is valued quite expensive, but it does show an excellent growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year CYN has reported negative net income.
In the past year CYN has reported a negative cash flow from operations.
CYN had negative earnings in each of the past 5 years.
In the past 5 years CYN always reported negative operating cash flow.
CYN Yearly Net Income VS EBIT VS OCF VS FCFCYN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -5M -10M -15M -20M -25M

1.2 Ratios

Looking at the Return On Assets, with a value of -54.30%, CYN is doing worse than 85.77% of the companies in the same industry.
Looking at the Return On Equity, with a value of -65.23%, CYN is doing worse than 74.38% of the companies in the same industry.
Industry RankSector Rank
ROA -54.3%
ROE -65.23%
ROIC N/A
ROA(3y)-115.88%
ROA(5y)-101.42%
ROE(3y)-182.19%
ROE(5y)-146.11%
ROIC(3y)N/A
ROIC(5y)N/A
CYN Yearly ROA, ROE, ROICCYN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -50 -100 -150 -200 -250

1.3 Margins

CYN does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CYN Yearly Profit, Operating, Gross MarginsCYN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 -2K -4K -6K

More info and screens

7

2. Health

2.1 Basic Checks

CYN does not have a ROIC to compare to the WACC, probably because it is not profitable.
CYN has more shares outstanding than it did 1 year ago.
The number of shares outstanding for CYN has been increased compared to 5 years ago.
CYN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
CYN Yearly Shares OutstandingCYN Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50K 100K 150K
CYN Yearly Total Debt VS Total AssetsCYN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

Based on the Altman-Z score of -2.83, we must say that CYN is in the distress zone and has some risk of bankruptcy.
CYN has a Altman-Z score of -2.83. This is in the lower half of the industry: CYN underperforms 79.72% of its industry peers.
CYN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -2.83
ROIC/WACCN/A
WACC11.33%
CYN Yearly LT Debt VS Equity VS FCFCYN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 10M -10M 20M -20M

2.3 Liquidity

CYN has a Current Ratio of 14.54. This indicates that CYN is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 14.54, CYN belongs to the top of the industry, outperforming 96.09% of the companies in the same industry.
A Quick Ratio of 14.22 indicates that CYN has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 14.22, CYN belongs to the top of the industry, outperforming 96.09% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 14.54
Quick Ratio 14.22
CYN Yearly Current Assets VS Current LiabilitesCYN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

More info and screens

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 83.85% over the past year.
The Revenue has grown by 444.99% in the past year. This is a very strong growth!
Measured over the past years, CYN shows a very strong growth in Revenue. The Revenue has been growing by 25.13% on average per year.
EPS 1Y (TTM)83.85%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%99.56%
Revenue 1Y (TTM)444.99%
Revenue growth 3YN/A
Revenue growth 5Y25.13%
Sales Q2Q%289.04%

3.2 Future

Based on estimates for the next years, CYN will show a very strong growth in Earnings Per Share. The EPS will grow by 28.40% on average per year.
CYN is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 168.10% yearly.
EPS Next Y99.74%
EPS Next 2Y41.37%
EPS Next 3Y28.4%
EPS Next 5YN/A
Revenue Next Year-72.38%
Revenue Next 2Y107.52%
Revenue Next 3Y168.1%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CYN Yearly Revenue VS EstimatesCYN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2022 2023 2024 2025 2026 2027 10M 20M 30M
CYN Yearly EPS VS EstimatesCYN Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 -5K -10K -15K -20K

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CYN. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CYN. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CYN Price Earnings VS Forward Price EarningsCYN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CYN Per share dataCYN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -200 -400 -600 -800

4.3 Compensation for Growth

A more expensive valuation may be justified as CYN's earnings are expected to grow with 28.40% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.37%
EPS Next 3Y28.4%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CYN!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CYNGN INC

NASDAQ:CYN (10/2/2025, 8:00:01 PM)

After market: 6.1 -0.12 (-1.93%)

6.22

+0.39 (+6.69%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)08-06 2025-08-06/amc
Earnings (Next)11-04 2025-11-04
Inst Owners9.82%
Inst Owner Change-86.85%
Ins Owners0%
Ins Owner Change0%
Market Cap43.79M
Analysts80
Price Target12.24 (96.78%)
Short Float %10.32%
Short Ratio1.91
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-23.46%
Min EPS beat(2)-49.37%
Max EPS beat(2)2.44%
EPS beat(4)2
Avg EPS beat(4)-6.72%
Min EPS beat(4)-49.37%
Max EPS beat(4)23.9%
EPS beat(8)5
Avg EPS beat(8)0.82%
EPS beat(12)9
Avg EPS beat(12)4.06%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-93.49%
Min Revenue beat(2)-96.29%
Max Revenue beat(2)-90.69%
Revenue beat(4)0
Avg Revenue beat(4)-76.17%
Min Revenue beat(4)-96.29%
Max Revenue beat(4)-24.26%
Revenue beat(8)0
Avg Revenue beat(8)-80.44%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)61.09%
EPS NY rev (1m)34.62%
EPS NY rev (3m)34.62%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-93.33%
Revenue NY rev (1m)-89.54%
Revenue NY rev (3m)-89.54%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 100.69
P/FCF N/A
P/OCF N/A
P/B 0.94
P/tB 1
EV/EBITDA N/A
EPS(TTM)-923.12
EYN/A
EPS(NY)-3.67
Fwd EYN/A
FCF(TTM)-1.83
FCFYN/A
OCF(TTM)-1.71
OCFYN/A
SpS0.06
BVpS6.64
TBVpS6.21
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -54.3%
ROE -65.23%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-115.88%
ROA(5y)-101.42%
ROE(3y)-182.19%
ROE(5y)-146.11%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 101.26%
Cap/Sales 190.14%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 14.54
Quick Ratio 14.22
Altman-Z -2.83
F-Score6
WACC11.33%
ROIC/WACCN/A
Cap/Depr(3y)139.74%
Cap/Depr(5y)N/A
Cap/Sales(3y)236.57%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)83.85%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%99.56%
EPS Next Y99.74%
EPS Next 2Y41.37%
EPS Next 3Y28.4%
EPS Next 5YN/A
Revenue 1Y (TTM)444.99%
Revenue growth 3YN/A
Revenue growth 5Y25.13%
Sales Q2Q%289.04%
Revenue Next Year-72.38%
Revenue Next 2Y107.52%
Revenue Next 3Y168.1%
Revenue Next 5YN/A
EBIT growth 1Y4.47%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year13.48%
EBIT Next 3Y32.43%
EBIT Next 5YN/A
FCF growth 1Y37.37%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y38.42%
OCF growth 3YN/A
OCF growth 5YN/A